Prime Bioresearch Limited ("PrimeBio") is an innovative targeted-drug acquisition and development company that specialises in personalised medicines for illnesses with large and growing markets such as Obesity, Type 2 Diabetes, and Cardiovascular Disorders. PrimeBio identifies, evaluates, and acquires promising patented lifescience research, and then develops each technology through strategic partnerships. The successful projects are then sold to Big Pharmaceuticals for commercialisation.
